Skip to content

Effect of novel combination of herbal extracts in type 2 diabetic patients indices

Effect of combination of Chromium, Cinnamon, Urtica, eryngium and D.sophia on glycemic, antioxidant, inflammatory indices, lipid profile and HOMA index in type 2 diabetic patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210530051441N1
Enrollment
60
Registered
2021-06-15
Start date
2021-06-04
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetes. Condition 2: immune and anti-oxidant system. Type 2 diabetes mellitus Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Intervention 1: Group 1 - Intervention: In this group, patients will receive 100 mg capsules containing herbal extract powder twice a day. The extracts have been purchased and the final combination fo

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Volunteered Type 2 Diabetes Mellitus (T2DM) age 30 - 60 No change in treatment and medications in at least the last 2 months Average level of physical activity body mass index between 25 and 30 HA1C between 25 and 30

Exclusion criteria

Exclusion criteria: Having diabetes for more than ten years Pregnancy and lactation Hospitalization during the study Patients with severe renal and hepatic impairment and any other acute illness Occurrence of any side effects due to the intervention Menopause and hormone therapy Diet change Changes in the physical activity level Taking any dietary supplement from 2 months before to the end of the study History of any allergies

Design outcomes

Primary

MeasureTime frame
Fasting Plasma Glucose (FBS). Timepoint: Benign of the study and after 8 weeks in the end of the study. Method of measurement: Biochemistry tests.

Secondary

MeasureTime frame
Plasma insuline. Timepoint: Benign of the study and after 8 weeks in the end of the study. Method of measurement: Biochemistry tests.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Shiri Shahsavar

Qazvin University of Medical Sciences

nutshiri@gmail.com+98 28 3336 9581

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026